India orders top drugmaker to halt eye medicine production at plant over quality lapses

·1h ago
Share:PostShare

Indian regulators have escalated action against India's largest drugmaker, Sun Pharma, barring ophthalmic drug production at its Assam factory until it submits a satisfactory compliance report.

C

Channel Newsasia

Original source

Read full story

Related Stories

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer